Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the pulmonary drug delivery devices market?
In the past few years, there has been a significant growth in the market size of pulmonary drug delivery devices. It’s expected to escalate from $49.52 billion in 2024 to approximately $53.21 billion in 2025 at a CAGR of 7.4%. Various factors contributing to this growth in the historical period include the rising cases of respiratory disorders like COPD, asthma, and cystic fibrosis, an increasing elderly population on a global scale, heightening awareness concerning respiratory well-being, burgeoning healthcare expenditure in developing economies, and a growing inclination towards homecare settings for the treatment of respiratory conditions.
What will be the pulmonary drug delivery devices market size in the future?
The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $69.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.
Get your pulmonary drug delivery devices market report here!
What main drivers are fueling expansion in the pulmonary drug delivery devices market?
The growing incidence of respiratory ailments is projected to boost the expansion of the market for pulmonary drug delivery devices. Respiratory ailments typically affect the lungs and air passages, thus influencing human breathing. Factors like elevating air pollutants, increasing smoking habits, urbanization, climate shifts, and an elderly population contribute to the upsurge of these disorders. Pulmonary drug delivery devices are integral to the treatment of these disorders as they allow medications to be delivered directly to the lungs. For instance, the Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, cited that the occurrence of asthma among adults aged 18 and above, rose from 8.0% in 2021 to 8.7% in 2022. Accordingly, the alarming rise in respiratory conditions is anticipated to drive the expansion of the market for pulmonary drug delivery devices.
What key areas define the segmentation of the global pulmonary drug delivery devices market?
The pulmonary drug delivery devices market covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
Who are the key firms paving the way for growth in the pulmonary drug delivery devices market?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
What key trends are currently impacting the pulmonary drug delivery devices market’s development?
Prominent organizations in the pulmonary drug delivery devices market are improving their offerings by creating ground-breaking products like small-volume nebulizers equipped with upgraded features for better customer satisfaction. A small-volume nebulizer (SVN) is a specialized tool used to administer aerosolized liquid medication to individuals dealing with respiratory issues such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For example, in May 2024, American healthcare giant Medline Industries LP introduced the Hudson RCI TurboMist small-volume nebulizer. This revolutionary tool is designed to deliver therapeutic treatments swiftly, in roughly three minutes. This cutting-edge nebulizer can administer 2.5 times more medicine per minute than traditional nebulizers, cutting treatment durations by roughly 70%. This boost in medication delivery drastically diminishes treatment durations, which aids healthcare providers by maximizing patient influx and enhancing patient experiences by curtailing therapy session durations.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15907
Which regions are emerging as leaders in the pulmonary drug delivery devices market?
North America was the largest region in the pulmonary drug delivery devices market in 2023. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Advanced Drug Delivery Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
